Australia Proposes Plan to Speed Drug Approvals

The proposed pathways are intended to accelerate drug approvals. Read More

Senators Urge DOJ Probe of EpiPen Generic Classification

Mylan paid a 13 percent Medicaid rebate rather than the standard 23.1 percent. Read More
The Solutions Center